flag
Insights into Essex Partnerships deployment of OxevisionDownload
Download
arrow right
cross

Company

21
April
2021
FDA grants Oxehealth Vital Signs De Novo clearance
31
March
2021

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision

31
March
2021
FDA grants Oxehealth Vital Signs De Novo clearance; Oxehealth launches in the US
31
March
2021

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.

09
March
2021
Oxehealth's Charlotte Wood named one of twelve innovators selected to scale across England’s NHS with support from the NHS Innovation Accelerator
08
March
2021

Oxehealth's Oxevision named one of 12 high impact innovations to join the NHS Innovation Accelerator in 2021.

08
March
2021
Oxehealth Featured By Healthcare UK As One Of The “First 100” Digital Health Companies
24
February
2021

We at Oxehealth are delighted to announce that we've been selected as one of the “First 100 Digital Health Companies” by Healthcare UK. The list was announced by Healthcare UK this morning.

1 / 5
arrow right